Kornitzer Capital Management’s Kymera Therapeutics KYMR Stock Holding History

Kornitzer Capital Management’s Portfolio KYMR Stock Details KYMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.36M	Buy	+20,620	New	+$1.77M	0.05%	286

Other funds holding KYMR

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

KOCAA

Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return

LBP AM Paris, France $10B AUM 43.88% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Kornitzer Capital Management's KYMR Position: Q2 2026 in Review

Kornitzer Capital Management opened a new position in Kymera Therapeutics (KYMR) in Q2 2026: 20,620 shares worth $2.36M. The stake represents 0.05% of the portfolio and ranks #286 among its holdings.

49 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

Kornitzer Capital Management held 20,620 shares of Kymera Therapeutics worth $2.36M as of Q2 2026.
Kymera Therapeutics was a new Kornitzer Capital Management position in Q2 2026.
Kymera Therapeutics made up 0.05% of Kornitzer Capital Management's portfolio in Q2 2026, its #286 holding.
49 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.